Compugen (CGEN) Enterprise Value Growth (3y) (2012 - 2026)
Compugen (CGEN) Enterprise Value Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.28% |
| Dec 31, 2025 | -622.20% |
| Sep 30, 2025 | 12.37% |
| Jun 30, 2025 | 12.58% |
| Mar 31, 2025 | 12.71% |
| Dec 31, 2024 | 12.05% |
| Sep 30, 2024 | 8.02% |
| Jun 30, 2024 | 18.87% |
| Mar 31, 2024 | 16.67% |
| Dec 31, 2023 | 30.75% |
| Sep 30, 2023 | 28.89% |
| Jun 30, 2023 | 23.06% |
| Mar 31, 2023 | 15.04% |
| Dec 31, 2022 | 78.15% |
| Sep 30, 2022 | -22.80% |
| Jun 30, 2022 | -38.05% |
| Mar 31, 2022 | -40.94% |
| Dec 31, 2021 | -11.30% |
| Sep 30, 2021 | -43.09% |
| Jun 30, 2021 | -37.12% |